"Designing Growth Strategies is in our DNA"

Antipsychotic Drugs Market Size, Share & COVID-19 Impact Analysis, By Disease (Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, and Others), By Drug (Risperidone, Quetiapine, Olanzapine, Aripiprazole, Brexpiprazole, Paliperidone Palmitate, and Others), By Therapeutic Class (First Generation, Second Generation, and Third Generation), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2022-2029

Region : Global | Format: PDF | Report ID: FBI101390

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Psychiatric Disorders, By Key Countries/Regions
    2. Analysis of the Cost and Burden of Mental Health Disorders
    3. Overview of Current Advances in R&D for Antipsychotic Drugs
    4. Pipeline Analysis
    5. Analysis of Antipsychotics in Treatment of Dementia
    6. Analysis: First Generation Antipsychotics vs. Third Generation Antipsychotics
    7. Key Industry Developments
    8. New Product Launches
    9. Impact of COVID-19 on Antipsychotic Drugs Market
  5. Global Antipsychotic Drugs Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast– By Disease
      1. Schizophrenia  
      2. Bipolar Disorder
      3. Unipolar Depression
      4. Dementia
      5. Others
    2. Market Analysis, Insights and Forecast– By Drug
      1. Risperidone
      2. Quetiapine
      3. Olanzapine
      4. Aripiprazole
      5. Brexpiprazole
      6. Paliperidone Palmitate
      7. Others
    3. Market Analysis, Insights and Forecast – By Therapeutic Class
      1. First Generation
      2. Second Generation
      3. Third Generation
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Antipsychotic Drugs Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast– By Disease
      1. Schizophrenia  
      2. Bipolar Disorder
      3. Unipolar Depression
      4. Dementia
      5. Others
    2. Market Analysis, Insights and Forecast– By Drug
      1. Risperidone
      2. Quetiapine
      3. Olanzapine
      4. Aripiprazole
      5. Brexpiprazole
      6. Paliperidone Palmitate
      7. Others
    3. Market Analysis, Insights and Forecast – By Therapeutic Class
      1. First Generation
      2. Second Generation
      3. Third Generation
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast  – By Country
      1. U.S.
        1. By Disease
      2. Canada
        1. By Disease
  7. Europe Antipsychotic Drugs Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast– By Disease
      1. Schizophrenia  
      2. Bipolar Disorder
      3. Unipolar Depression
      4. Dementia
      5. Others
    2. Market Analysis, Insights and Forecast– By Drug
      1. Risperidone
      2. Quetiapine
      3. Olanzapine
      4. Aripiprazole
      5. Brexpiprazole
      6. Paliperidone Palmitate
      7. Others
    3. Market Analysis, Insights and Forecast – By Therapeutic Class
      1. First Generation
      2. Second Generation
      3. Third Generation
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. Germany
        1. By Disease
      2. U.K.
        1. By Disease
      3. France
        1. By Disease
      4. Italy
        1. By Disease
      5. Spain
        1. By Disease
      6. Scandinavia
        1. By Disease
      7. Rest of Europe
        1. By Disease
  8. Asia Pacific Antipsychotic Drugs Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast– By Disease
      1. Schizophrenia  
      2. Bipolar Disorder
      3. Unipolar Depression
      4. Dementia
      5. Others
    2. Market Analysis, Insights and Forecast– By Drug
      1. Risperidone
      2. Quetiapine
      3. Olanzapine
      4. Aripiprazole
      5. Brexpiprazole
      6. Paliperidone Palmitate
      7. Others
    3. Market Analysis, Insights and Forecast – By Therapeutic Class
      1. First Generation
      2. Second Generation
      3. Third Generation
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. China
        1. By Disease
      2. India
        1. By Disease
      3. Japan
        1. By Disease
      4. Australia
        1. By Disease
      5. Southeast Asia
        1. By Disease
      6. Rest of Asia Pacific
        1. By Disease
  9. Latin America Antipsychotic Drugs Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast– By Disease
      1. Schizophrenia  
      2. Bipolar Disorder
      3. Unipolar Depression
      4. Dementia
      5. Others
    2. Market Analysis, Insights and Forecast– By Drug
      1. Risperidone
      2. Quetiapine
      3. Olanzapine
      4. Aripiprazole
      5. Brexpiprazole
      6. Paliperidone Palmitate
      7. Others
    3. Market Analysis, Insights and Forecast – By Therapeutic Class
      1. First Generation
      2. Second Generation
      3. Third Generation
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. Brazil
        1. By Disease
      2. Mexico
        1. By Disease
      3. Rest of Latin America
        1. By Disease
  10. Middle East & Africa Antipsychotic Drugs Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast– By Disease
      1. Schizophrenia  
      2. Bipolar Disorder
      3. Unipolar Depression
      4. Dementia
      5. Others
    2. Market Analysis, Insights and Forecast– By Drug
      1. Risperidone
      2. Quetiapine
      3. Olanzapine
      4. Aripiprazole
      5. Brexpiprazole
      6. Paliperidone Palmitate
      7. Others
    3. Market Analysis, Insights and Forecast – By Therapeutic Class
      1. First Generation
      2. Second Generation
      3. Third Generation
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. GCC
        1. By Disease
      2. South Africa
        1. By Disease
      3. Rest of Middle East & Africa
        1. By Disease
  11. Competitive Analysis
    1. Global Market Share Analysis (2021)
    2. Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based On Availability))
      1. Otsuka Pharmaceutical Co., Ltd.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      2. Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      3. Teva Pharmaceutical Industries Ltd.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      4. Dr. Reddy’s Laboratories Ltd.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      5. H. Lundbeck A/S
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      6. ALLERGAN (AbbVie, Inc.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      7. Eli Lilly and Company
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      8. Alkermes plc
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      9. Bristol-Myers Squibb Company
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      10. Sumitomo Dainippon Pharma Co., Ltd.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
Read Less

Figure 01: Global Antipsychotic Drugs Market Value Share (%), By Disease, 2021 & 2029

Figure 02: Global Antipsychotic Drugs Market Value Share (%), By Drug, 2021 & 2029

Figure 03: Global Antipsychotic Drugs Market Value Share (%), By Therapeutic Class, 2021 & 2029

Figure 04: Global Antipsychotic Drugs Market Value Share (%), By Distribution Channel, 2021 & 2029

Figure 05: Global Antipsychotic Drugs Market Value Share (%), By Region, 2021 & 2029

Figure 06: North America Antipsychotic Drugs Market Value (USD billion), By Disease, 2021 & 2029

Figure 07: North America Antipsychotic Drugs Market Value Share (%), By Disease, 2021

Figure 08: North America Antipsychotic Drugs Market Value (USD billion), By Drug, 2021 & 2029

Figure 09: North America Antipsychotic Drugs Market Value Share (%), By Drug, 2021

Figure 10: North America Antipsychotic Drugs Market Value (USD billion), By Therapeutic Class, 2021 & 2029

Figure 11: North America Antipsychotic Drugs Market Value Share (%), By Therapeutic Class, 2021

Figure 12: North America Antipsychotic Drugs Market Value (USD billion), By Distribution Channel, 2021 & 2029

Figure 13: North America Antipsychotic Drugs Market Value Share (%), By Distribution Channel, 2021

Figure 14: North America Antipsychotic Drugs Market Value (USD billion), By Country, 2021 & 2029

Figure 15: North America Antipsychotic Drugs Market Value Share (%), By Country, 2021

Figure 16: Europe Antipsychotic Drugs Market Value (USD billion), By Disease, 2021 & 2029

Figure 17: Europe Antipsychotic Drugs Market Value Share (%), By Disease, 2021

Figure 18: Europe Antipsychotic Drugs Market Value (USD billion), By Drug, 2021 & 2029

Figure 19: Europe Antipsychotic Drugs Market Value Share (%), By Drug, 2021

Figure 20: Europe Antipsychotic Drugs Market Value (USD billion), By Therapeutic Class, 2021 & 2029

Figure 21: Europe Antipsychotic Drugs Market Value Share (%), By Therapeutic Class, 2021

Figure 22: Europe Antipsychotic Drugs Market Value (USD billion), By Distribution Channel, 2021 & 2029

Figure 23: Europe Antipsychotic Drugs Market Value Share (%), By Distribution Channel, 2021 & 2029

Figure 24: Europe Antipsychotic Drugs Market Value (USD billion), By Country/Sub-region, 2021 & 2029

Figure 25: Europe Antipsychotic Drugs Market Value Share (%), By Country/Sub-region, 2021

Figure 26: Asia Pacific Antipsychotic Drugs Market Value (USD billion), By Disease, 2021 & 2029

Figure 27: Asia Pacific Antipsychotic Drugs Market Value Share (%), By Disease, 2021

Figure 28: Asia Pacific Antipsychotic Drugs Market Value (USD billion), By Drug, 2021 & 2029

Figure 29: Asia Pacific Antipsychotic Drugs Market Value Share (%), By Drug, 2021

Figure 30: Asia Pacific Antipsychotic Drugs Market Value (USD billion), By Therapeutic Class, 2021 & 2029

Figure 31: Asia Pacific Antipsychotic Drugs Market Value Share (%), By Therapeutic Class, 2021

Figure 32: Asia Pacific Antipsychotic Drugs Market Value (USD billion), By Distribution Channel, 2021 & 2029

Figure 33: Asia Pacific Antipsychotic Drugs Market Value Share (%), By Distribution Channel, 2021

Figure 34: Asia Pacific Antipsychotic Drugs Market Value (USD billion), By Country/ Sub-region, 2021 & 2029

Figure 35: Asia Pacific Antipsychotic Drugs Market Value Share (%), By Country/ Sub-region, 2021

Figure 36: Latin America Antipsychotic Drugs Market Value (USD billion), By Disease, 2021 & 2029

Figure 37: Latin America Antipsychotic Drugs Market Value Share (%), By Disease, 2021

Figure 38: Latin America Antipsychotic Drugs Market Value (USD billion), By Drug, 2021 & 2029

Figure 39: Latin America Antipsychotic Drugs Market Value Share (%), By Drug, 2021

Figure 40: Latin America Antipsychotic Drugs Market Value (USD billion), By Therapeutic Class, 2021 & 2029

Figure 41: Latin America Antipsychotic Drugs Market Value Share (%), By Therapeutic Class, 2021

Figure 42: Latin America Antipsychotic Drugs Market Value (USD billion), By Distribution Channel, 2021 & 2029

Figure 43: Latin America Antipsychotic Drugs Market Value Share (%), By Distribution Channel, 2021

Figure 44: Latin America Antipsychotic Drugs Market Value (USD billion), By Country/ Sub-region, 2021 & 2029

Figure 45: Latin America Antipsychotic Drugs Market Value Share (%),

Figure 46: Middle East & Africa Antipsychotic Drugs Market Value (USD billion), By Disease, 2021 & 2029

Figure 47: Middle East & Africa Antipsychotic Drugs Market Value Share (%), By Disease, 2021

Figure 48: Middle East & Africa Antipsychotic Drugs Market Value (USD billion), By Drug, 2021 & 2029

Figure 49: Middle East & Africa Antipsychotic Drugs Market Value Share (%),

Figure 50: Middle East & Africa Antipsychotic Drugs Market Value (USD billion), By Therapeutic Class, 2021 & 2029

Figure 51: Middle East & Africa Antipsychotic Drugs Market Value Share (%), By Therapeutic Class, 2021

Figure 52: Middle East & Africa Antipsychotic Drugs Market Value (USD billion), By Distribution Channel 2021 & 2029

Figure 53: Middle East & Africa Antipsychotic Drugs Market Value Share (%), By Distribution Channel, 2021

Figure 54: Middle East & Africa Antipsychotic Drugs Market Value (USD billion), By Country/ Sub-region, 2021 & 2029

Figure 55: Middle East & Africa Antipsychotic Drugs Market Value Share (%), By Country/ Sub-region, 2021

Table 01: Global Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2018–2029

Table 02: Global Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Drug, 2018–2029

Table 03: Global Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Therapeutic Class, 2018–2029

Table 04: Global Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2018–2029

Table 05: Global Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Region, 2018–2029

Table 06: North America Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2018–2029

Table 07: North America Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Drug, 2018–2029

Table 08: North America Antipsychotic Drugs Revenue (USD billion) Forecast, By Therapeutic Class, 2018–2029

Table 09: North America Antipsychotic Drugs Revenue (USD billion) Forecast, By Distribution Channel, 2018–2029

Table 10: North America Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Country, 2018–2029

Table 11: U.S. Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2018–2029

Table 12: Canada Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2018–2029

Table 13: Europe Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2018–2029

Table 14: Europe Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Drug, 2018–2029

Table 15: Europe Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Therapeutic Class, 2018–2029

Table 16: Europe Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2018–2029

Table 17: Europe Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2018–2029

Table 18: Germany Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2018–2029

Table 19: U.K. Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2018–2029

Table 20: France Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2018–2029

Table 21: Italy Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2018–2029

Table 22: Spain Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2018–2029

Table 23: Scandinavia Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2018–2029

Table 24: Rest of Europe Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2018–2029

Table 25: Asia Pacific Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2018–2029

Table 26: Asia Pacific Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Drug, 2018–2029

Table 27: Asia Pacific Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Therapeutic Class, 2018–2029

Table 28: Asia Pacific Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2018–2029

Table 29: Asia Pacific Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2018–2029

Table 30: Asia Pacific Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2018–2029

Table 31: China Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2018–2029

Table 32: India Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2018–2029

Table 33: Japan Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2018–2029

Table 34: Australia Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2018–2029

Table 35: South East Asia Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2018–2029

Table 36: Rest of Asia Pacific Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2018–2029

Table 37: Latin America Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2018–2029

Table 38: Latin America Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Drug, 2018–2029

Table 39: Latin America Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Therapeutic Class, 2018–2029

Table 40: Latin America Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2018–2029

Table 41: Latin America Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2018–2029

Table 42: Brazil Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2018–2029

Table 43: Mexico Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2018–2029

Table 44: Rest of Latin America Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2018–2029

Table 45: Middle East & Africa Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2018–2029

Table 46: Middle East & Africa Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Drug, 2018–2029

Table 47: Middle East & Africa Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Therapeutic Class, 2018–2029

Table 48: Middle East & Africa Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2018–2029

Table 49: Middle East & Africa Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2018–2029

Table 50: South Africa Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2018–2029

Table 51: GCC Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2018–2029

Table 52: Rest of Middle East & Africa Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2018–2029

Booklet
  • May, 2022
  • 2021
  • 2018-2020
  • 195

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $7850
    Book Now

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X